1. Home
  2. AMRX vs APLE Comparison

AMRX vs APLE Comparison

Compare AMRX & APLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • APLE
  • Stock Information
  • Founded
  • AMRX 2002
  • APLE 2007
  • Country
  • AMRX United States
  • APLE United States
  • Employees
  • AMRX N/A
  • APLE N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • APLE Real Estate Investment Trusts
  • Sector
  • AMRX Health Care
  • APLE Real Estate
  • Exchange
  • AMRX Nasdaq
  • APLE Nasdaq
  • Market Cap
  • AMRX 2.4B
  • APLE 2.7B
  • IPO Year
  • AMRX N/A
  • APLE 2015
  • Fundamental
  • Price
  • AMRX $7.41
  • APLE $11.75
  • Analyst Decision
  • AMRX Strong Buy
  • APLE Buy
  • Analyst Count
  • AMRX 5
  • APLE 4
  • Target Price
  • AMRX $10.80
  • APLE $17.25
  • AVG Volume (30 Days)
  • AMRX 2.1M
  • APLE 2.7M
  • Earning Date
  • AMRX 05-02-2025
  • APLE 05-01-2025
  • Dividend Yield
  • AMRX N/A
  • APLE 8.59%
  • EPS Growth
  • AMRX N/A
  • APLE N/A
  • EPS
  • AMRX N/A
  • APLE 0.79
  • Revenue
  • AMRX $2,830,186,000.00
  • APLE $1,429,658,000.00
  • Revenue This Year
  • AMRX $10.49
  • APLE $2.20
  • Revenue Next Year
  • AMRX $7.00
  • APLE $2.73
  • P/E Ratio
  • AMRX N/A
  • APLE $14.79
  • Revenue Growth
  • AMRX 13.42
  • APLE 4.98
  • 52 Week Low
  • AMRX $5.18
  • APLE $10.44
  • 52 Week High
  • AMRX $9.48
  • APLE $16.50
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 46.13
  • APLE 45.73
  • Support Level
  • AMRX $7.15
  • APLE $11.26
  • Resistance Level
  • AMRX $8.02
  • APLE $12.04
  • Average True Range (ATR)
  • AMRX 0.32
  • APLE 0.30
  • MACD
  • AMRX 0.02
  • APLE 0.06
  • Stochastic Oscillator
  • AMRX 31.07
  • APLE 41.88

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About APLE Apple Hospitality REIT Inc.

Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.

Share on Social Networks: